Skip to content

A OPEN LABEL CLINICAL COMPARATIVE STUDY OF KARVEER TAIL AND KARVEER CREAM ON KIKKISA WITH SPECIAL REFERENCE TO STRIAE GRAVIDARUM

AN OPEN LABELLED CLINICAL COMPARATIVE STUDY OF KARVEER TAIL AND KARVEER CREAM ON KIKKISA WITH SPECIAL REFERENCE TO STRIAE GRAVIDARUM.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042417
Enrollment
60
Registered
2022-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

SANEGURUJI AROGYA KENDRA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PRIMI GRAVIDA OF 18 TO 30 YEARS OF AGE. FROM 23RD WEEK UPTO DELIVERY.

Exclusion criteria

Exclusion criteria: MULTI PARA. SKIN DISEASE. POLY HYDROMNIOS.

Design outcomes

Primary

MeasureTime frame
TO STUDY THE EFFECT OF KARVEER CREAM AND KARVEER TAIL ON KIKKISA WITH SPECIAL REFERENCE TO STRIAE GRAVIDARUMTimepoint: TREATMENT WILL BE GIVEN FOR 120DAYS. PATIENT WILL BE ASSESSED ON 0,15,30,60,90 AND 120TH DAY.

Secondary

MeasureTime frame
LITERATURE STUDY OF KIKKISA AND STRAIE GRAVIDRAUMTimepoint: STUDY WILL BE DONE USING AYURVEDIC GRANTHAS AND MODERN TEXT;TO OBSERVE ADVERSE EFFECT IF ANYTimepoint: DURING TREATMENT OBSERVATION WILL BE DONE FOR ANY ADVERSE EFFECT ON PATIENTS;TO PREPARE KARVEER CREAM AND KARVEER TAILTimepoint: PREPARATION OF DRUGS WILL BE DONE ACCORDING TO PROCEDURE

Countries

India

Contacts

Public ContactDR BHAGYASHREE SURESHRAO HEMKE

SUMATIBHAI SHAH AYURVED MAHAVIDYALAYA

mandaghorpade@yahoo.com9822007570

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026